Literature DB >> 22191992

A family with branchio-oculo-facial syndrome with primarily ocular involvement associated with mutation of the TFAP2A gene.

Alina V Dumitrescu1, Jeff M Milunsky, Susannah Q Longmuir, Arlene V Drack.   

Abstract

BACKGROUND: Branchio-Oculo-Facial syndrome (BOFS) is a rare, autosomal dominant developmental disorder that has a distinct phenotype with characteristic craniofacial abnormalities. We report a family with extensive ocular manifestations of BOFS caused by a novel mutation in the transcription factor AP-2 alpha (TFAP2A) gene.
MATERIALS AND METHODS: Case report of phenotypic and genotypic characterization of a family with BOFS.
RESULTS: An infant presenting with anophththalmia/coloboma and subtle craniofacial symptoms was found to have a family history of congenital cataracts and colobomas in her mother. A mutation in the TFAP2A gene associated with BOFS (heterozygous H384Y in exon 7) was found in both the proband and her mother. This mutation had not been reported previously. Compared with other molecularly confirmed cases in the literature, this family has primarily ocular features, which are severe.
CONCLUSIONS: BOFS can have profound ocular involvement without prominent extraocular features. When the syndrome presents in this way, it may be confused with isolated autosomal dominant chorioretinal coloboma. Testing for mutations in the TFAP2A gene is recommended to establish an accurate diagnosis for the family.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22191992     DOI: 10.3109/13816810.2011.634878

Source DB:  PubMed          Journal:  Ophthalmic Genet        ISSN: 1381-6810            Impact factor:   1.803


  8 in total

1.  AP-2α is required after lens vesicle formation to maintain lens integrity.

Authors:  Christine L Kerr; Mizna A Zaveri; Michael L Robinson; Trevor Williams; Judith A West-Mays
Journal:  Dev Dyn       Date:  2014-04-30       Impact factor: 3.780

2.  Overlapping expression patterns and redundant roles for AP-2 transcription factors in the developing mammalian retina.

Authors:  Erin A Bassett; Anna Korol; Paula A Deschamps; Reinhard Buettner; Valerie A Wallace; Trevor Williams; Judith A West-Mays
Journal:  Dev Dyn       Date:  2012-04       Impact factor: 3.780

3.  Analysis of TFAP2A mutations in Branchio-Oculo-Facial Syndrome indicates functional complexity within the AP-2α DNA-binding domain.

Authors:  Hong Li; Ryan Sheridan; Trevor Williams
Journal:  Hum Mol Genet       Date:  2013-04-10       Impact factor: 6.150

4.  Tfap2a and 2b act downstream of Ptf1a to promote amacrine cell differentiation during retinogenesis.

Authors:  Kangxin Jin; Haisong Jiang; Dongchang Xiao; Min Zou; Jun Zhu; Mengqing Xiang
Journal:  Mol Brain       Date:  2015-05-13       Impact factor: 4.041

5.  Case report of homozygous deletion involving the first coding exons of GCNT2 isoforms A and B and part of the upstream region of TFAP2A in congenital cataract.

Authors:  Hannah Happ; Eric Weh; Deborah Costakos; Linda M Reis; Elena V Semina
Journal:  BMC Med Genet       Date:  2016-09-08       Impact factor: 2.103

6.  Multimodal Imaging of Large Optic Disc Coloboma: A Report of Three Cases.

Authors:  Sophia El Hamichi; Dhariana Acón; Timothy G Murray; Audina M Berrocal
Journal:  Case Rep Ophthalmol       Date:  2020-11-10

7.  KCTD1 mutants in scalp‑ear‑nipple syndrome and AP‑2α P59A in Char syndrome reciprocally abrogate their interactions, but can regulate Wnt/β‑catenin signaling.

Authors:  Lingyu Hu; Li Chen; Liu Yang; Zi Ye; Wenhuan Huang; Xinxin Li; Qing Liu; Junlu Qiu; Xiaofeng Ding
Journal:  Mol Med Rep       Date:  2020-08-24       Impact factor: 2.952

8.  Long Noncoding RNA OIP5-AS1 Promotes Cell Apoptosis and Cataract Formation by Blocking POLG Expression Under Oxidative Stress

Authors:  Ruihua Jing; Bo Ma; Tiantian Qi; Conghui Hu; Chongbing Liao; Chan Wen; Yongping Shao; Cheng Pei
Journal:  Invest Ophthalmol Vis Sci       Date:  2020-10-01       Impact factor: 4.799

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.